Risk of Autoimmune Hepatitis Among Patients with Inflammatory Bowel Disease Treated with Infliximab: A Retrospective Cohort Study Using a National Database. - Almusabeh H; Kovach Z; Lloyd L; Alzaher MZ; Teran D; Adeniran O; Shepherd K; Elfert K; Goswami S; Tandon K; Hadam-Veverka J (Digestive diseases and sciences, 2026)